ReproTech

What ReproTech does

ReproTech is a U.S. cryostorage provider specializing in long-term preservation of reproductive specimens — embryos, oocytes, sperm, ovarian tissue, and testicular tissue — for fertility clinics and patients. Founded in 1990 and headquartered in Columbia, the company operates disaster-safe biorepositories built to withstand hurricanes, tornadoes, and wildfires, currently at five pre-merger U.S. locations (Trumbull CT, Coconut Creek FL, Twin Cities MN, Reno NV, Plano TX) and expanding to eight offsite facilities following its April 2026 strategic combination with TMRW Life Sciences. Post-merger, the combined entity safeguards over one million fertility specimens, partners with approximately 75% of U.S. fertility centers, and supports more than 50% of U.S. patient cycles. Customers include IVF centers (Mayo Clinic, Northwestern Medicine, University of Miami, Augusta University, Dallas IVF among them) and end-patients seeking elective fertility preservation, oncofertility protection, gender transition preservation, military deployment, or vasectomy-related storage.

ReproTech's technology stack centers on four integrated components: TMRW Digital Specimen Management (automated storage and digital chain-of-custody), Matcher electronic witnessing (IVF process traceability), Cryologix (an all-in-one platform for billing, collections, specimen tracking, and customer communications from post-freeze through disposition), and Reprotech Guardian (on-site tank monitoring with real-time tracking and predictive analysis). The company maintains full compliance with FDA 1271 and AATB standards, redundant 24/7 tank monitoring, and FedEx-based logistics for the OverNite Male Kit direct-to-consumer offering. Clinical workflow integration is anchored by an EngagedMD partnership embedding Reprotech consent forms into a platform serving 250+ fertility clinics and 17M+ informed consent forms.

ReproTech operates a B2B-led sales motion with annual subscription-based storage fees as the primary recurring revenue stream, supplemented by one-time transactions from specimen shipping/transport and the OverNite Male Kit at-home sperm banking package. The OverNite Male Kit is processed by the University of Illinois at Chicago Andrology Lab (FDA-registered, CLIA-certified, CAP-accredited) before transfer to ReproTech for long-term storage. Patient acquisition is supported by financial assistance programs (Verna's Purse for cancer patients, Anna's Gift for hardship cases, Military Support Program) and partnerships with Livestrong, Ferring/Walgreens Heart Beat, Heart for Heroes, and Compassionate Corps. Following the TMRW combination, the merged entity is led by former TMRW CEO Louis Villalba as CEO and former ReproTech CEO Brad Senstra as COO.

Name

ReproTech

Legal name

ReproTech LLC

Website

https://www.reprotech.com/

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

101–250 employees

Short description

ReproTech is a U.S. fertility cryostorage provider safeguarding over one million reproductive specimens across eight offsite biorepositories, serving approximately 75% of U.S. fertility centers through B2B clinic partnerships and integrated digital specimen management, electronic witnessing, and patient consent platforms.

Ownership category

akta.pro rank

Product category

Reproductive Cryostorage Services

NAICS

Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD)

Keywords

• Cryostorage services
• Reproductive tissue banking
• Fertility preservation
• Specimen management
• Long-term biorepository storage

Headquarters

HQ city

Columbia

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Infrastructure, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Cryostorage Services: Long-term storage fees for embryos, eggs, sperm, ovarian tissue, and testicular tissue. Subscription-based recurring revenue model with annual or multi-year billing cycles. Includes testing requirements (HIV, Hepatitis B/C) and potentially infectious storage programs for reactive results.
2. OverNite Male Kit: At-home sperm banking collection kit sold as an all-inclusive package including collection kit, semen analysis, processing, all required lab testing, overnight FedEx delivery, and one year of storage. One-time purchase model with option for additional kits.
3. Shipping and Transport Services: Transportation of reproductive specimens in specialized cryogenic tanks with GPS tracking. Includes shipping liability protection options and coordination with clinics for specimen transfers.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

ReproTech provides long-term cryogenic storage and management services for reproductive specimens, including embryos, eggs (oocytes), sperm, ovarian tissue, and testicular tissue. The company operates a national network of disaster-safe biorepositories serving fertility clinics and individual patients, complemented by the OverNite Male Kit at-home sperm banking product. Following its 2026 strategic combination with TMRW Life Sciences, ReproTech also offers proprietary digital platforms for specimen management, electronic witnessing, and cryostorage operations.

Product overview

Reprotech is a comprehensive technology-enabled cryostorage company in the fertility industry. Following the 2026 strategic combination with TMRW Life Sciences, the organization operates a unified platform under the Reprotech banner, featuring TMRW Digital Specimen Management, Matcher digital witnessing and traceability, and Cryologix as an integrated management platform. The core service offering includes cryopreservation storage for embryos, eggs (oocytes), sperm, ovarian tissue, and testicular tissue. The company also offers the OverNite Male Kit for at-home sperm banking. The combined entity safeguards over one million fertility specimens, partners with approximately 75% of U.S. fertility centers, and operates eight offsite storage facilities nationwide.

Differentiator

Problem solved

Functional benefit

Brands

• TMRW: Digital Specimen Management platform and automated storage technology for fertility cryostorage, now part of the Reprotech combined entity.
• Matcher
• Cryologix

Products and services

• Embryo Storage Long-term cryopreservation storage for embryos resulting from the combination of oocytes and sperm, supporting infertility treatment and fertility preservation against age, medical treatment, or other life circumstances.
• Sperm Storage Cryopreservation storage for sperm/semen specimens, offering options for those facing cancer treatment, military deployment, or gender transition. Includes the OverNite Male Kit option for remote at-home collection.
• Egg (Oocyte) Storage Secure, long-term cryopreservation storage for oocytes for elective fertility preservation, cancer treatment preparation, military deployment, or gender transition purposes.
• Ovarian Tissue Storage Cryopreservation storage for ovarian tissue, particularly important for young women and girls preparing for cancer treatment that may affect fertility.
• Testicular Tissue Storage Cryopreservation storage for testicular tissue for young men and boys who cannot produce a semen sample before cancer treatment, preserving fertility options.
• OverNite Male Kit At-home sperm banking collection kit enabling discreet private sample collection and overnight shipment to a partner andrology lab (UIC) for semen analysis, processing, lab testing, and freezing, followed by automatic transfer to ReproTech for one year of long-term storage. Sold as an all-inclusive package.
• Reprotech Guardian Proprietary on-site tank monitoring application that provides comprehensive monitoring of tank health on one screen, tracks and trends tank health in real time, and enables predictive analysis for cryogenic tank operations.
• TMRW Digital Specimen Management Digital Specimen Management platform with automated storage technology providing digital innovation for fertility cryostorage, now part of the combined Reprotech entity.
• Matcher Digital witnessing and traceability technology for IVF processes providing electronic witnessing and unbroken chain of custody for fertility specimens, redefining clinic workflows.
• Cryologix All-in-one platform for managing long-term cryostorage integrating billing, collections, specimen tracking, and customer communications from post-freeze through disposition, reducing administrative burden for IVF centers.
• Reprotech Cryostorage Services Comprehensive cryostorage services for reproductive specimens including end-to-end clinic coordination, safe specimen transport in specialized cryogenic tanks with GPS tracking, and long-term storage across disaster-safe biorepositories nationwide.

Quantifiable outcome

• Safeguards over 1 million fertility specimens
• +3 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• TMRW Life SciencescoreStrategic or Co-development Partner · 2 April 2026Reprotech and TMRW Life Sciences entered into a strategic business combination to create the most comprehensive technology-enabled cryostorage company in the fertility industry. The combined entity operates under the Reprotech banner, merging Reprotech's 35+ years of cryostorage leadership and national biorepository network with TMRW's Digital Specimen Management platform and automated storage technology. Post-merger, the combined entity safeguards over 1 million fertility specimens, partners with approximately 75% of U.S. fertility centers, supports more than 50% of U.S. patient cycles, and operates 8 offsite storage facilities. TMRW CEO Louis Villalba leads the combined company as CEO, with Reprotech CEO Brad Senstra serving as COO.
• EngagedMDcoreTechnology or Integration · 25 February 2026Reprotech partnered with EngagedMD to integrate off-site storage consent workflows into its digital platform, allowing fertility clinics to manage consent forms electronically. The integration embeds Reprotech's storage and transportation consent forms directly into EngagedMD's digital platform, which serves over 250 fertility clinics worldwide and has facilitated more than 17 million informed consent forms. The partnership aims to reduce manual paperwork, improve operational continuity, and strengthen compliance documentation.
• Livestrong FoundationminorGTM or Marketing PartnerPartnership with Livestrong provides financial assistance to cancer patients seeking fertility preservation services. Applications are processed quickly by Livestrong, with many Reprotech partner clinics participating in the program.
• Ferring Pharmaceuticals / Walgreens Heart Beat ProgramminorGTM or Marketing PartnerThe Heart Beat Program provides eligible cancer patients with reduced costs for fertility medications through Ferring and Walgreens Specialty Pharmacy.
• University of Illinois at Chicago Andrology LabcoreImplementation/ SI/ Consulting PartnerPartner lab for the OverNite Male Kit. The University Andrology Laboratory, relocated in 1996 to UIC Medical Center's Department of Urology, is directed by Gail S. Prins, PhD, HCLD. It is FDA-registered, CLIA-certified, and CAP-accredited, processing and freezing specimens from the OverNite Male Kit before transfer to Reprotech for long-term storage.

Scale indicators8 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Xytex Cryo International: Xytex Cryo International is a sperm and reproductive tissue bank offering donor specimens and long-term storage. Direct competitor to Reprotech in cryobank services, with overlapping services around sperm banking, embryo storage, and assisted reproduction.
• TMRW Life Sciences (now part of Reprotech): TMRW Life Sciences, which merged into Reprotech, was a digital specimen management and automated cryostorage platform. Historically a direct competitor/innovator in the same fertility cryostorage space before becoming a sub-brand of Reprotech post-merger.
• Fairfax Cryobank: Fairfax Cryobank is a long-established U.S. sperm bank and reproductive tissue storage provider serving patients and clinics. Direct competitor to Reprotech across donor sperm, long-term sperm storage, and cryostorage services, with overlapping customer base of fertility clinics and individual patients.
• Seattle Sperm Bank: Seattle Sperm Bank is a major donor sperm bank and reproductive tissue storage provider with nationwide distribution. Competes directly with Reprotech's sperm storage and OverNite Male Kit offerings, serving similar patient segments and fertility clinic networks.
• New England Cryogenic Center: New England Cryogenic Center provides long-term storage of reproductive tissue for fertility clinics and patients in the Northeast U.S. Direct competitor to Reprotech for off-site cryostorage services with similar biological product custody and chain-of-custody operations.
• California Cryobank (now part of Cryoport): California Cryobank, acquired by Cryoport, is one of the largest reproductive tissue banks in the U.S. offering sperm, egg, and embryo storage directly comparable to Reprotech's long-term cryostorage services. Both serve fertility clinics and patients with similar biological material custody and chain-of-custody requirements.

Emerging players

• Hamilton Thorne: Hamilton Thorne provides precision instruments, software, and automation for the IVF and animal breeding markets. Adjacent to Reprotech's clinic-facing digital platform strategy via Matcher and Cryologix, serving overlapping fertility clinic customers with ART lab equipment.

Broad incumbents

• CooperSurgical: CooperSurgical is a major fertility and women's health medical device company offering ART and IVF supplies and services. Broad incumbent in fertility space with overlapping clinic relationships and complementary offerings in IVF lab products, though not specialized in long-term cryostorage.
• Cryoport Systems: Cryoport provides temperature-controlled logistics and cryogenic storage across life sciences including reproductive health, with a broader portfolio spanning biopharma, animal health, and clinical trials. Comparable to Reprotech in cryogenic handling expertise and specimen transport, but operating across far more verticals.

Regional players

• Donor Nexus: Donor Nexus and affiliated donor networks provide egg and sperm donor services with storage coordination, competing with Reprotech in patient-facing fertility preservation services. Smaller, niche player focused on donor matching with comparable cryogenic logistics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/reprotechcryo
• LinkedInlinkedin.com/company/reprotech-llc
• Instagraminstagram.com/reprotech_cryo
• Xx.com/reprotechltd

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ReproTech